For adults with moderate-to-severe obstructive sleep apnea (OSA), proximal hypoglossal nerve stimulation (pHGNS) yields a ...
MedPage Today on MSN
Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy
Investigational deramiocel is back under FDA review again ...
Here’s what you’ll learn when you read this story: Mammals aren’t exactly known for their limb-regenerating abilities, but ...
Probable cause affidavits detail new allegations against LaQuaris Living and her boyfriend, Christopher Elam, who were ...
Cirrhotic ascites is driven by proximal tubular sodium reabsorption, mainly via NHE3. Due to spatial coupling of NHE3 and SGLT2, SGLT2 inhibitors ...
The randomized PRO-TAVI trial showed that in patients with coronary artery disease undergoing transcatheter aortic valve ...
Exposure to wildfire smoke may raise risk for several types of cancer, according to an analysis of data from a large ...
Nectero Therapeutics, a clinical-stage biotechnology company developing therapies for aneurysmal disease, released two-year outcomes data today from the company’s first-in-human (FIH) trial of their ...
In higher education, the most pressing challenge is not AI itself, but the underlying pedagogy gap masked by traditional ...
The data show a correlation between wound healing and better participation in social activities, better sleeping habits, and ...
LivaNova has published 12-month data supporting its proximal hypoglossal nerve stimulation (pHGNS) system for sleep apnea.
A randomized controlled trial evaluating the safety and efficacy of proximal hypoglossal nerve stimulation, or pHGNS, (an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results